M
Manimegalai
About Manimegalai
Data last updated:
Manimegalai is a Director at Firstmed Therapeutics Private Limited (since 2024) and Director at Curio Pharmaceuticals Private Limited (since 2020). The companies operate in Pharma. The largest current company by reported revenue is Firstmed Therapeutics Private Limited at ₹5.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Firstmed Therapeutics Private Limited U24232TN2012PTC136229 | Director | 18 May 2024 | 2012 | ₹5.38 Cr (FY 2025) | Active |
| Curio Pharmaceuticals Private Limited U24290PY2020PTC008635 | Director | 20 Nov 2020 | 2020 | Active |
Board colleagues of Manimegalai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramakrishnan | 07288290 | Firstmed Therapeutics Private Limited , Curio Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manimegalai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manimegalai
Manimegalai currently holds 2 directorships: Firstmed Therapeutics Private Limited (Director, since 18 May 2024, revenue ₹5.38 Cr (FY 2025)); Curio Pharmaceuticals Private Limited (Director, since 20 Nov 2020).
Manimegalai was first appointed on 20 Nov 2020 as Director at Curio Pharmaceuticals Private Limited. The most recent appointment on record is 18 May 2024 at Firstmed Therapeutics Private Limited.
The current boards of Manimegalai's companies include Ramakrishnan (Firstmed Therapeutics Private Limited).